The rising interest in GLP-1 agonists for diabetes has generated a discussion about application forms : skin-applied devices versus capsules. Typically, GLP-1 therapies were exclusively available in https://zakariazpao805324.activoblog.com/51826619/glp-1-transdermal-delivery-systems-vs-pills-which-best-for-the-patient